Evidence map›Paper›PMID 26219670›Full record

Trial reportBMC cancer2015

Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial).

Leonie Haverkamp, Hylke J F Brenkman, Maarten F J Seesing, Suzanne S Gisbertz, Mark I van Berge Henegouwen, Misha D P Luyer, Grard A P Nieuwenhuijzen, Bas P L Wijnhoven, Jan J B van Lanschot, Wobbe O de Steur and 16 more

Registry-linked trialAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02248519 (Laparoscopic Versus Open Gastrectomy for Gastric Cancer, a Multicenter Prospectively Randomized Controlled Trial), which is not on this map. Cited by 51 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02248519 nacompletednot on this map

Laparoscopic Versus Open Gastrectomy for Gastric Cancer, a Multicenter Prospectively Randomized Controlled Trial (LOGICA-trial)

TypeinterventionalSponsorUMC UtrechtRan2014 to 2023Enrolled210ConditionsGastric CancerArmsOpen Gastrectomy, Laparoscopic Gastrectomy
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Short-term outcomes in minimally invasive versus open gastrectomy: the differences between East and West. A systematic review of the literature.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2018
    Pooled it
  6. Pooled it
  7. Laparoscopic versus open gastrectomy for gastric cancer.The Cochrane database of systematic reviews · 2016
    Pooled it
  8. Trial
  9. Trial
  10. Pattern of lymph node metastases in gastric cancer: a side-study of the multicenter LOGICA-trial.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2022
    Trial
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Leonie HaverkampUniversity Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. Leonie.Haverkamp@gmail.com.
Hylke J F BrenkmanUniversity Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. H.J.F.Brenkman@umcutrecht.nl.
Maarten F J SeesingUniversity Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. M.F.J.Seesing@umcutrecht.nl.
Suzanne S GisbertzAcademic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. S.S.Gisbertz@amc.uva.nl.
Mark I van Berge HenegouwenAcademic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. M.I.vanBergeHenegouwen@amc.uva.nl.
Misha D P LuyerCatharina Hospital, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands. Misha.Luyer@catharinaziekenhuis.nl.
Grard A P NieuwenhuijzenCatharina Hospital, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands. Grard.Nieuwenhuijzen@catharinaziekenhuis.nl.
Bas P L WijnhovenErasmus Medical Center, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. B.Wijnhoven@erasmusmc.nl.
Jan J B van LanschotErasmus Medical Center, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. J.vanLanschot@erasmusmc.nl.
Wobbe O de SteurLeiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. W.O.deSteur@lumc.nl.
Henk H HartgrinkLeiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. H.H.Hartgrink@lumc.nl.
Jan H M B StootZuyderland Medical Center, Dr. H. van der Hoffplein 1, 6162 BG Sittard-Geleen, The Netherlands. J.Stoot@orbisconcern.nl.
Karel W E HulsewéZuyderland Medical Center, Dr. H. van der Hoffplein 1, 6162 BG Sittard-Geleen, The Netherlands. K.Hulsewe@orbisconcern.nl.
Ernst J Spillenaar BilgenRijnstate Hospital, Wagnerlaan 55, 6815AD , Arnhem, The Netherlands. ESpillenaarBilgen@rijnstate.nl.
Jeroen E RütterRijnstate Hospital, Wagnerlaan 55, 6815AD , Arnhem, The Netherlands. JRutter@rijnstate.nl.
Ewout A KouwenhovenZGT Hospitals, location Almelo, Zilvermeeuw 1, 7609 PP, Almelo, The Netherlands. E.Kouwenhoven@zgt.nl.
Marc J van DetZGT Hospitals, location Almelo, Zilvermeeuw 1, 7609 PP, Almelo, The Netherlands. M.vDet@zgt.nl.
Donald L van der PeetVU University Medical Center, De Boelelaan 1117, 1081 HZ, Amsterdam, The Netherlands. DL.vanderPeet@vumc.nl.
Freek DaamsVU University Medical Center, De Boelelaan 1117, 1081 HZ, Amsterdam, The Netherlands. F.Daams@vumc.nl.
Werner A DraaismaMeander Medical Center, Maatweg 3, 3813 TZ, Amersfoort, The Netherlands. WA.Draaisma@meandermc.nl.
Ivo A M J BroedersMeander Medical Center, Maatweg 3, 3813 TZ, Amersfoort, The Netherlands. IAMJ.Broeders@meandermc.nl.
Henk F van StelUniversity Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. H.vanStel@umcutrecht.nl.
Miangela M LacleUniversity Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. M.M.Lacle@umcutrecht.nl.
Jelle P RuurdaUniversity Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. J.P.Ruurda@umcutrecht.nl.
Richard van HillegersbergUniversity Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. R.vanHillegersberg@umcutrecht.nl.
LOGICA study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFor gastric cancer patients, surgical resection with en-bloc lymphadenectomy is the cornerstone of curative treatment. Open gastrectomy has long been the preferred surgical approach worldwide. However, this procedure is associated with considerable morbidity. Several meta-analyses have shown an advantage in short-term outcomes of laparoscopic gastrectomy compared to open procedures, with similar oncologic outcomes. However, it remains unclear whether the results of these Asian studies can be extrapolated to the Western population. In this trial from the Netherlands, patients with resectable gastric cancer will be randomized to laparoscopic or open gastrectomy.

methodsThe study is a non-blinded, multicenter, prospectively randomized controlled superiority trial. Patients (≥18 years) with histologically proven, surgically resectable (cT1-4a, N0-3b, M0) gastric adenocarcinoma and European Clinical Oncology Group performance status 0, 1 or 2 are eligible to participate in the study after obtaining informed consent. Patients (n = 210) will be included in one of the ten participating Dutch centers and are randomized to either laparoscopic or open gastrectomy. The primary outcome is postoperative hospital stay (days). Secondary outcome parameters include postoperative morbidity and mortality, oncologic outcomes, readmissions, quality of life and cost-effectiveness. DISCUSSION: In this randomized controlled trial laparoscopic and open gastrectomy are compared in patients with resectable gastric cancer. It is expected that laparoscopic gastrectomy will result in a faster recovery of the patient and a shorter hospital stay. Secondly, it is expected that laparoscopic gastrectomy will be associated with a lower postoperative morbidity, less readmissions, higher cost-effectiveness, better postoperative quality of life, but with similar mortality and oncologic outcomes, compared to open gastrectomy. The study started on 1 December 2014. Inclusion and follow-up will take 3 and 5 years respectively. Short-term results will be analyzed and published after discharge of the last randomized patient.

trial registrationNCT02248519.

Indexed as

AdenocarcinomaCost-Benefit AnalysisGastrectomyHumansLaparoscopyLength of StayNetherlandsPostoperative ComplicationsProspective StudiesQuality of LifeStomach NeoplasmsSurvival AnalysisTreatment Outcome

Identifiers

PMID26219670
PMCPMC4518687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.